Clinical Trials Directory

Trials / Recruiting

RecruitingNCT05578196

Fecal Microbial Transplantation in Critically Ill Patients With Severe Infections.

Fecal Microbial Transplantation in Critically Ill Patients With Severe Infections:A Randomized Clinical Trial

Status
Recruiting
Phase
N/A
Study type
Interventional
Enrollment
110 (estimated)
Sponsor
Shanghai 10th People's Hospital · Academic / Other
Sex
All
Age
14 Years
Healthy volunteers
Not accepted

Summary

Fecal microbial transplantation is to transplant functional microbiota from the feces of healthy people into the gastrointestinal tract of patients, reconstruct new intestinal microbiota, and realize the treatment of intestinal and extra-intestinal diseases. Compared with ordinary commercial probiotics, FMT is more consistent with the composition of the intestinal microecological structure and can recover intestinal flora to the maximum extent and faster. FMT increases intestinal bacteria production function and helps to restore the systemic immune response so that sepsis pathogens are removed. The aim of this trial was to investigate the clinical effect of FMT in the treatment of patients with severe infections.

Detailed description

The gastrointestinal tube access was established, and the standard preparation of fecal bacteria solution 20ml (frozen at -80 ° C, melted at room temperature before use) was injected through the gastrointestinal tube once a day for 6 consecutive days. The other treatment measures were the same as those of the control group.

Conditions

Interventions

TypeNameDescription
DRUGfecal bacteria solutionThe gastrointestinal tube access was established, and the standard preparation of fecal bacteria solution 20ml (frozen at -80 ° C, melted at room temperature before use) was injected through the gastrointestinal tube once a day for 6 consecutive days. The other treatment measures were the same as those of the control group.
DRUGphysiological saline solutionphysiological saline solution 20ml

Timeline

Start date
2022-09-04
Primary completion
2024-12-31
Completion
2025-12-31
First posted
2022-10-13
Last updated
2024-05-17

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT05578196. Inclusion in this directory is not an endorsement.